(Q40885287)

24 September 2017

title

Therapeutic efficiency of IL-2 gene transduced tumor vaccine for head and neck carcinoma (English)

1 reference

24 September 2017

Mizuno H

1

1 reference

24 September 2017

Yanoma S

2

1 reference

24 September 2017

Nishimura G

3

1 reference

24 September 2017

Hattori S

4

1 reference

24 September 2017

Ito T

5

1 reference

24 September 2017

Okudera K

6

1 reference

24 September 2017

Tsukuda M

7

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

24 September 2017

1 reference

24 September 2017

volume

152

1 reference

24 September 2017

issue

2

1 reference

24 September 2017

page(s)

175-185

1 reference

Long term culture of tumour-specific cytotoxic T cells

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900336-0

7 January 2021

Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900336-0

7 January 2021

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900336-0

7 January 2021

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900336-0

7 January 2021

Intratumoral rIL2-based immunotherapy in B16 melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900336-0

7 January 2021

Analysis of cytolytic effector cell response in vitro against autologous human tumor cells genetically altered to synthesize interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900336-0

7 January 2021

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900336-0

7 January 2021

Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900336-0

7 January 2021

The herpes simplex virus amplicon: A new eucaryotic defective-virus cloning-amplifying vector

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900336-0

7 January 2021

Expression of a functional foreign gene in adult mammalian brain following in Vivo transfer via a herpes simplex virus type 1 defective viral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900336-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900336-0

1 reference

7 January 2021

Cancer statistics, 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900336-0

7 January 2021

Two types of mouse helper T-cell clone Implications for immune regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900336-0

7 January 2021

Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900336-0

7 January 2021

The biology and clinical applications of interleukin 2

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900336-0

7 January 2021

Rapid production of interleukin-2-secreting tumor cells by herpes simplex virus-mediated gene transfer: implications for autologous vaccine production

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900336-0

7 January 2021

Generation of interleukin-2-secreting melanoma cell populations from resected metastatic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900336-0

7 January 2021

Interleukin-2 gene transduction into freshly isolated lung adenocarcinoma cells with adenoviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900336-0

7 January 2021

Interleukin-2 gene-transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900336-0

7 January 2021

Transduction of the IL2 gene into human acute leukemia cells: induction of tumor rejection without modifying cell proliferation and IL2 receptor expression

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900336-0

7 January 2021

Interferon: a cytotoxic T lymphocyte differentiation signal

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900336-0

7 January 2021

γ Interferon induced by S. aureus protein A augments natural killing and ADCC

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900336-0

7 January 2021

Molecular transductional mechanisms by which IFN gamma and other signals regulate macrophage development

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900336-0

7 January 2021

Transduction of human melanoma cells with interleukin-2 gene reduces tumorigenicity and enhances host antitumor immunity: a nude mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900336-0

7 January 2021

10.1016/S0304-3835(00)00336-0

Identifiers

DOI

1 reference

24 September 2017

1 reference